DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.10
-0.40 (-5.33%)
Jul 29, 2026, 4:00 PM EDT - Market closed
DarioHealth Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -40.74 | -41.71 | -42.75 | -62.19 | -76.76 | -29.45 |
Depreciation & Amortization | 2.41 | 3.14 | 7.43 | 4.72 | 4.46 | 0.19 |
Stock-Based Compensation | 8.46 | 9.37 | 15.8 | 16.98 | 24.97 | 11.1 |
Other Adjustments | 2.48 | 1.66 | -15.08 | 2.64 | -0.29 | 0.27 |
Change in Receivables | 0.99 | 2.66 | 1.68 | -5.11 | -0.35 | 0.55 |
Changes in Inventories | 0.45 | 0.44 | 0.31 | -1.73 | -2.23 | -0.88 |
Changes in Accounts Payable | 0.71 | -0.12 | -0.5 | -2.79 | 1.08 | 0.82 |
Changes in Accrued Expenses | 0.55 | -0.78 | -3.48 | -1.31 | -0.87 | 1.05 |
Changes in Unearned Revenue | -0.8 | -0.87 | -0.16 | 0.13 | -0.16 | 0 |
Changes in Other Operating Activities | 0.24 | 0.29 | -1.81 | 0.83 | -0.26 | -1.39 |
Operating Cash Flow | -25.29 | -25.94 | -38.56 | -47.85 | -50.41 | -17.74 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.14 | -0.14 | -0.14 | -0.44 | -0.26 | -0.12 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | - |
Purchases of Intangible Assets | - | - | - | -0.13 | - | - |
Purchases of Investments | - | -4.2 | - | - | - | -0 |
Proceeds from Sale of Investments | 4.2 | - | - | - | - | - |
Cash Acquisitions | - | - | -8.8 | - | -7.47 | - |
Other Investing Activities | - | - | - | - | -0.4 | -1.5 |
Investing Cash Flow | -5.14 | -4.34 | -8.93 | -0.57 | -8.13 | -1.62 |
Long-Term Debt Issued | - | 31.7 | - | 23.79 | - | - |
Long-Term Debt Repaid | - | -31.52 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | 0.19 | - | 23.79 | - | - |
Issuance of Common Stock | - | 17.37 | - | 38.29 | 65.77 | 27.55 |
Repurchase of Common Stock | - | - | - | -0.13 | - | - |
Net Common Stock Issued (Repurchased) | - | 17.37 | - | 38.15 | 65.77 | 27.55 |
Issuance of Preferred Stock | -0.06 | 6.75 | 38.53 | - | - | - |
Net Preferred Stock Issued (Repurchased) | -0.06 | 6.75 | 38.53 | - | - | - |
Financing Cash Flow | 17.5 | 24.31 | 38.53 | 61.94 | 65.77 | 27.55 |
Foreign Exchange Rate Adjustments | 0.06 | 0.01 | -0.07 | - | - | - |
Net Cash Flow | -12.93 | -5.97 | -8.97 | 13.52 | 7.22 | 8.19 |
Free Cash Flow | -25.44 | -26.08 | -38.7 | -48.29 | -50.67 | -17.85 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -120.03% | -116.66% | -143.12% | -174.60% | -247.01% | -235.67% |
Free Cash Flow Per Share | -5.06 | -6.55 | -15.78 | -40.86 | -61.08 | -59.88 |
Levered Free Cash Flow | -52.51 | -59.6 | -39.33 | -40.65 | -77 | -33.43 |
Unlevered Free Cash Flow | -31.27 | -34.8 | -53.69 | -57.41 | -74.76 | -30.23 |